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Because of concerns about zoonotic transmission of monkeypox to humans and the bioterrorism threat posed by orthopoxviruses, there is
renewed interest in probing cellular and molecular mechanisms of host defense to these pathogens. In particular, it is essential to understand viral–
host interactions in the respiratory tract, which is the route of infection for smallpox and a likely route of transmission for monkeypox. In this study,
we analyze functions of alveolar macrophages in poxvirus infection, using a recombinant vaccinia virus expressing firefly luciferase to quantify
infection in mice and cell culture. Depletion of alveolar macrophages with liposomal clodronate worsens the overall severity of infection in mice,
including greater replication and systemic dissemination of vaccinia as determined by bioluminescence imaging. Absence of alveolar macrophages
increases total numbers of granulocytes and granulocytes/monocyte progenitor cells in the lungs during vaccinia infection, indicating that protective
effects of alveolar macrophages may be mediated in part by reducing the host inflammation. Alveolar macrophages also limit vaccinia infection in
respiratory epithelium, as shown by a co-culture model of cell lines derived from alveolar macrophages and lung epithelium. Collectively, these data
demonstrate that alveolar macrophages are key determinants of host defense against local and systemic infection with poxviruses.
© 2007 Elsevier Inc. All rights reserved.Keywords: Vaccinia; Macrophage; ImagingThe respiratory tract is a key route of spread for orthopox-
viruses, including the viruses that cause smallpox andmonkeypox
(Fenner et al., 1988). In addition, the potential use of these viruses
as agents of biological warfare raises the possibility for exposure
to levels of aerosolized viruses that markedly exceed doses
encountered during normal infection. Therefore, defining cellular
and molecular determinants of the host response to poxviruses in
the respiratory system is essential for understanding basic
questions about host immunity to these pathogens and limiting
the bioterrorism threat posed by poxviruses.
Host defense against poxviruses in the respiratory tract begins
at the level of infected cells, which likely are epithelial cells.
Infected cells initiate an intracellular anti-viral response to limit⁎ Corresponding author. University of Michigan Medical School, Department
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doi:10.1016/j.virol.2007.01.033viral replication and secrete interferons and other anti-viral
cytokines as part of the local innate immune response. Local
immunity is amplified through macrophages and dendritic cells,
which also migrate to draining lymph nodes to activate adaptive
immunity. Ultimately, local innate immunity and systemic
adaptive immunity combine to control acute infection and
establish lasting immunity against subsequent poxvirus infection.
Alveolar macrophages are the predominant resident phago-
cytic cells in the lungs that respond to inhaled organisms in the
respiratory tract, initiate local immune responses to pathogens,
and maintain functional integrity of lung epithelium. Under
basal conditions, alveolar macrophages appear to promote an
immunosuppressive microenvironment in the lungs. These cells
suppress activation of adaptive immunity by limiting access of
antigens to dendritic cells and reducing functions of dendritic
cells, T cells, and B cells (MacLean et al., 1996; Thepen et al.,
1994). In response to bacterial pathogens, alveolar macrophages
Fig. 1. Depletion of alveolar macrophages with clodronate liposomes. 129 Ev/Sv
mice were injected intratracheally with 100 μl of liposomes containing
clodronate or saline as a control. Total numbers of cells recovered from
bronchoalveolar lavage fluid were quantified at different time points after
treatment (n=3 per time point). Data are expressed as the percent of cells
recovered relative to mice that did not receive either clodronate or saline
liposomes (n=3). Error bars represent SEM.
49R. Rivera et al. / Virology 363 (2007) 48–58decrease the overall severity of disease, in part by reducing
levels of pro-inflammatory cytokines and recruitment of
leukocytes to the lungs (Broug-Holub et al., 1997; Knapp et
al., 2003). However, functions of these cells in the context of
viral infections remain poorly defined, particularly for respira-
tory infection with poxviruses.
We investigated alveolar macrophages in host defense to
poxviruses, using a recombinant vaccinia virus that expresses
firefly luciferase as a model for analyzing functions of these
cells in local and systemic responses to infection. In mice, we
found that depletion of alveolar macrophages increases local
and systemic replication of vaccinia virus and overall severity of
disease. Absence of alveolar macrophages increases recruitment
of inflammatory cells to the lungs during vaccinia infection,
which likely contributes to more severe disease in these
animals. Alveolar macrophages also significantly limit infection
of lung epithelial cells in an in vitro co-culture model system.
Collectively, our results demonstrate functions of alveolar
macrophages to limit viral replication and disease severity in
response to infection with an orthopoxvirus.
Results
Depletion of alveolar macrophages with liposomal clodronate
Treatment of mice with liposomes containing the bispho-
sphonate compound clodronate is a well-established method for
depleting alveolar macrophages, a cell population that com-
prises >95% of cells in the normal airway. This technique does
not damage respiratory epithelium or cause toxicity to
neutrophils, another phagocytic cell type (van Rooijen, 1989)
(Qian et al., 1994).
To establish the kinetics of macrophage depletion, we
intratracheally injected 100 μl of liposomes containing
clodronate or saline as a control (clodronate liposomes) into
Sv129/Ev mice. Sv129/Ev mice have been used by our
laboratory and others for studies of vaccinia pathogenesis
(van den Broek et al., 1995) (Luker et al., 2005). Numbers of
alveolar macrophages recovered by bronchoalveolar lavage
were quantified at various times after treatment and compared
with alveolar macrophages in untreated, strain-matched mice. In
mice treated with clodronate liposomes, only ≈5% of alveolar
macrophages remained on day 2, and numbers of alveolar
macrophages were≤25% of normal through 7 days (Fig. 1). By
comparison, treatment with saline liposomes had only a
minimal effect on numbers of alveolar macrophages. These
data show that we are able to effectively deplete alveolar
macrophages for most of the expected period of acute infection
with vaccinia virus.
Some populations of dendritic cells may be depleted by
clodronate liposomes (Leenen et al., 1998), although effects of
this treatment on lung dendritic cells remain poorly defined. We
quantified numbers of dendritic cells in lungs of mice treated
with clodronate or control saline liposomes. Clodronate
liposomes did not affect total numbers of CD11c(+), MHC
class II(+) dendritic cells in the lung interstitium as compared
with control liposomes. In both groups, dendritic cells comprised≈0.8% of total cells in the lungs, which is consistent with our
previous data from untreated mice. Because antigen presenting
cells such as dendritic cells and macrophages migrate to regional
lymph nodes to initiate adaptive immunity, we also quantified
numbers of these cell types in the tracheobronchial lymph node
of mice 2 days after injection of liposomes. There were no
significant differences between clodronate and saline control
mice in numbers or percentages of CD11c(+), MHC class II(+)
dendritic cells, Mac-3(+) macrophages, or ERMP-20(+) late
monocyte progenitors in these lymph nodes (data not shown).
Furthermore, numbers or percentages of dendritic cells and
macrophages in peripheral blood, as determined by these same
cell surface markers, did not differ between mice 2 days
following treatmentwith clodronate or saline liposomes (data not
shown). Collectively, these data demonstrate that intratracheal
administration of clodronate liposomes depleted only alveolar
macrophages.
Alveolar macrophages limit vaccinia infection in vivo
We treated mice with intratracheal administration of
clodronate liposomes to investigate effects of alveolar macro-
phages on host defense against respiratory infection with
vaccinia virus. Mice were injected with clodronate liposomes
and then infected with 4×105 pfu Vac-FL intranasally 2 days
later at a time when alveolar macrophages are depleted
maximally as shown above. Control mice received liposomes
filled with saline 2 days prior to infection. Mice were inoculated
with vaccinia intranasally to reproduce infection through the
upper respiratory tract, the typical route of transmission for
smallpox. In this and subsequent experiments, two mice each
treated with clodronate or saline liposomes were euthanized at
the time of infection with vaccinia to confirm effective depletion
of alveolar macrophages relative to saline control (data not
shown).
Depletion of alveolar macrophages increased the overall
severity of vaccinia infection relative to saline controls, as
Table 1
Area-under-the-curve (AUC) photon flux days 4–6 from 4×105 pfu infection
Liposomes Head Chest Abdomen
Saline 2.3×106 7.36×105 2.94×105
Clodronate 2.9×106 9.78×105 3.95×105
AUC values for mice treated with clodronate liposomes are significantly greater
than those for control saline liposomes (p<0.05) (n=5 mice per group).
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infection (Fig. 2A). Differences in weight loss became apparent
by day 3 after infection and persisted through day 7. Notably,
mice treated with clodronate liposomes to deplete alveolar
macrophages died on day 7 post-infection, while control
animals survived through day 8 of acute infection.
We used bioluminescence imaging to quantify viral replica-
tion and dissemination over the course of infection. Mice treated
with clodronate liposomes had higher levels of luciferase
activity in the head, chest, and abdomen on days 4–6 post-
infection than control mice (Figs. 2B–E). By area-under-curveFig. 2. Alveolar macrophages limit vaccinia virus infection.Mice were treatedwith int
4×105 pfu Vac-FL intranasally (n=5mice per group). (A)Mice were weighed daily to
loss of initial weight. (B) Representative bioluminescent images on day 4 of Vac-FL in
in the lungs (arrow) and spread to inguinal lymph node (asterisk) is greater in mice trea
photon flux data from the head (C), chest (D), and abdomen (E) regions-of-interest.(AUC) analysis of these days, total bioluminescence for each
region of interest was significantly greater in mice treated with
clodronate liposomes (Table 1) (p<0.05). On day 7 afterratracheal injection of clodronate or saline liposomes 2 days prior to infectionwith
monitor overall progression of disease. Data are presented asmean±SEMpercent
fection in mice treated with clodronate or saline liposomes. Viral bioluminescence
ted with clodronate liposomes to deplete alveolar macrophages. (C–E) Quantified
Data are shown as mean values of background subtracted photon flux±SEM.
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were lower in mice treated with clodronate liposomes compared
with control animals. However, this decrease in biolumines-
cence may be due to poor perfusion of luciferin to sites of Vac-
FL in these mice because of severe systemic illness in mice
treated with clodronate liposomes rather than an actual decrease
in vaccinia virus. Collectively, these data show that alveolar
macrophages decrease the overall extent of vaccinia viral
infection after respiratory inoculation.
To build upon the data presented above with a lethal
inoculum of vaccinia virus, we then investigated functions of
alveolar macrophages in the context of a non-lethal infection.
Mice were treated with clodronate or control saline liposomes
and infected with 4×104 pfu Vac-FL 2 days later at a time
coinciding with maximum depletion of alveolar macrophages
by clodronate. Under these conditions, mice lost comparable
amounts of weight until day 8 post-infection, when weight
loss was greater in animals treated with clodronate liposomes.
These differences in weight loss persisted through day 12
(Fig. 3A).
In addition to weight, we measured rectal temperatures as
another determinant of overall severity of disease produced by
Vac-FL. Mice depleted of alveolar macrophages had a greater
loss of body temperature over the course of infection, and
differences between groups occurred earlier than we observed
with body weight (Fig. 3B). By day 6, mean body temperatures
in these mice had dropped by >4 °C, while control animals lost
<2 °C. Collectively, these data demonstrate that alveolar
macrophages reduce the overall severity of system disease
produced by non-lethal infection with vaccinia virus.
Differences in viral replication as quantified by biolumines-
cence imaging and plaque assay corresponded with protective
effects of alveolar macrophages in vaccinia infection. Lucifer-
ase activity produced by Vac-FL in the head, chest, and
abdomen regions-of-interest was higher in mice treated with
clodronate liposomes, with differences becoming apparent by
days 4–5 post-infection (Figs. 3C–E). In the abdomen, images
showed that Vac-FL localized predominantly to the spleen (data
not shown). By AUC analysis of photon flux over days 4–9
post-infection, bioluminescence from Vac-FL was significantly
greater in these three regions of interest for infection (Table 2)
(p<0.01).
To confirm imaging data, we euthanized three mice from
each cohort on days 3 and 5 post-infection to quantify amounts
of virus in selected organs by plaque assay. Titers of Vac-FL in
tracheas were approximately 2 logs greater in mice treated with
clodronate liposomes compared with control animals on days 3
and 5 post-infection (Figs. 3F–I). Interestingly, viral titers in the
lungs were comparable between both groups, implying that
differences in bioluminescence in the chest region-of-interest
may be the result of greater amounts of Vac-FL in tracheas.
Systemic spread of Vac-FL to the spleen was detected in mice
treated with clodronate liposomes on day 5, while animals
treated with saline liposomes had no detectable virus in the
spleen on either day. Neither group had detectable amounts of
Vac-FL in liver. Amounts of Vac-FL in brain were comparable
on day 5, which is consistent with our previous data suggestingthat vaccinia spreads to the brain by local extension from the
nasopharynx rather than systemic dissemination (Luker et al.,
2005). We also analyzed bronchoalveolar lavage fluids from
these mice for levels of interferon β, TNF-α, IL-6, and MCP-1,
but we detected no consistent differences in levels of these
cytokines produced by mice treated with clodronate versus
saline liposomes (data not shown). Overall, these data further
demonstrate that alveolar macrophages limit local infection
with vaccinia virus and emphasize that protective effects of
these cells extend beyond the lungs and impact the overall
severity of infection.
Depletion of alveolar macrophages enhances recruitment of
leukocytes to the lungs
Alveolar macrophages have been shown to regulate recruit-
ment of inflammatory cells to the lungs during infection with
bacterial pathogens including Klebsiella pneumoniae and Strep-
tococcus pneumoniae (Broug-Holub et al., 1997; Knapp et al.,
2003). To determine up to what extent alveolar macrophages
regulate leukocytes in the lungs during vaccinia infection, we
depleted alveolar macrophages with liposomal clodronate and
then analyzed total numbers and types of immune cells in the
lung interstitium on days 3 and 5 after infection with 4×105 pfu
Vac-FL. Numbers of cells in uninfected mice also were
determined and subtracted from values obtained in the infected
animals.
Depletion of alveolar macrophages with liposomal clodro-
nate significantly increased total numbers of CD45+ leukocytes
recruited to the lungs of infected mice (Fig. 4A). On both days
3 and 5 post-infection, there were approximately 3-fold more
total leukocytes present in mice treated with liposomal
clodronate and then infected with Vac-FL. By comparison,
total numbers of leukocytes in uninfected lungs did not differ
between mice injected with clodronate or saline liposomes
(data not shown).
We used flow cytometry to identify specific types of
leukocytes present in the lungs and effects of alveolar
macrophages on numbers of various cells present during
vaccinia infraction with 4×105 pfu. On day 3 post-infection,
mice treated with clodronate liposomes had significantly greater
numbers of Gr1(+) granulocytes relative to saline control (Fig.
4B). Depletion of alveolar macrophages also increased numbers
of cells expressing ER-MP20, a marker of precursor cells for
granulocytes/monocytes, on day 3 after infection with Vac-FL.
Numbers of Gr1(+) and ER-MP20(+) cells on day 5 of infection
remained higher in mice treated with clodronate liposomes as
compared with control, although total numbers of cells
expressing either marker decreased from day 3 in both
experimental groups (Fig. 4C). In addition, there were
significantly greater numbers of NK1.1(+) natural killer cells
present in lungs of mice treated with clodronate liposomes on
day 5. We did not detect differences in numbers of cells with
markers of T or B lymphocytes on either day (data not shown).
Although the alveolar space ultimately is repopulated by cells
recruited from the circulation, this process does not make a
significant impact on leukocytes in the lungs at these early times.
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Fig. 3. Protective effects of alveolar macrophages in sublethal vaccinia infection.
Mice (n=10) were injected intratracheally with clodronate or saline liposomes
and then infected 2 days later with 4×104 pfu of Vac-FL i.n. (A) Weight and (B)
rectal temperature were measured daily to monitor overall progression of
disease. Data are mean values±SEM for percent weight loss or temperature,
respectively. (C–E) Photon flux from regions-of-interest defined for the head
(C), chest (D), and abdomen (E) on bioluminescent images over the course of
infection. Data are mean values of background subtracted photon flux±SEM.
(F–I) Viral titers were quantified on days 3 and 5 post-infection (n=3 per group)
in the trachea (F), lung (G), brain (H), and spleen (I). Data are presented as mean
values for viral titers±SEM. 30 pfu/g tissue is the lower limit of detection for
viral titers.
Table 2
AUC photon flux days 4–9 from 4×104 pfu infection
Liposomes Head Chest Abdomen
Saline 5.82×105 2.61×105 2.09×105
Clodronate 2.74×106 9.59×105 3.03×105
AUC values for mice treated with clodronate liposomes are significantly greater
than those for control saline liposomes (p<0.01) (n=7 mice per group through
day 5, then n=4 per group on days 6–9).
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indirectly limit influx of selected populations of leukocytes into
the lungs during the course of infection with vaccinia virus.
Because alveolar macrophages have been proposed to limit
antigen presentation by resident dendritic cells in the pulmonary
interstitium, we also used flow cytometry to analyze expression
of co-stimulatory molecules on CD11c(+) cells in lung tissue.
Using CD11c as a marker of pulmonary dendritic cells, there
were no differences in total numbers of these cells in the lungs
between mice treated with clodronate or saline liposomes,
respectively (data not shown). However, depletion of alveolar
macrophages greatly enhanced the number of activated
CD11c(+) cells on both days 3 and 5 post-infection, as deter-
mined by increased expression of co-stimulatory molecules
CD80 or CD86 (Figs. 4D, E). These data for CD11c(+)
dendritic cells suggest that alveolar macrophages limit activa-
tion of dendritic cells during vaccinia infection, potentially
through direct suppression or indirectly by reducing amounts of
antigen available to dendritic cells.
Co-culture of alveolar macrophages with respiratory
epithelium reduces vaccinia infection and replication in vitro
Because alveolar macrophages limited replication of vacci-
nia virus in vivo, we further analyzed effects of these cells on
viral infection in respiratory epithelium in cultured cell lines
derived from alveolar macrophages and lung epithelium. MH-S
alveolar macrophages and LA-4 lung epithelial cells, which are
murine cell lines that have been used previously to analyze hostresponses to infection (Farbermann et al., 2004) (Tuthill et al.,
2003), were co-cultured in direct contact to model the dynamic
interactions between these cell types during infection in vivo.
For these experiments, we focused on co-cultures with 1% and
5% MH-S cells added to LA-4 cells for 48 h prior to infection.
Although it is difficult to determine the actual ratio of alveolar
macrophages to respiratory epithelium at a site of infection,
these percentages are lower than those published previously for
co-culture models and may more accurately reproduce condi-
tions in vivo (Hjort et al., 2003) (Ishii et al., 2005).
Cells were infected with Vac-FL, adjusting the total amount of
virus to account for differing total numbers of LA-4 and MH-S
cells in various wells, and we then quantified bioluminescence
24 h after infection. Wells with co-cultured MH-S and LA-4 cells
had significantly less bioluminescence from Vac-FL as compared
with LA-4 cells alone (Fig. 5A). Addition of as few as 1%MH-S
cells significantly limited expression of the reporter gene, and
protective effects were evident under both co-culture conditions
(p<0.05). To establish that co-cultures of respiratory epithelium
and alveolar macrophages also limited production of new viruses,
we quantified viral replication by plaque assay 24 h after infection
with Vac-FL at anMOI of 0.1. Addition of either 1%or 5%MH-S
macrophages to LA-4 epithelial cells significantly decreased
replication of Vac-FL relative to LA-4 cells alone (p<0.01) (Fig.
5B). Collectively, these data demonstrate that alveolar macro-
phages limit vaccinia infection in respiratory epithelium, which
may contribute in part to protective effects of alveolar macro-
phages during vaccinia infection in mice.
Type I interferons are key components of host defense
against vaccinia, which suggests that production of these
cytokines or genes activated by type I interferons could account
for protective effects of MH-S cells on infection of respiratory
epithelium by vaccinia. We measured levels of interferon β, a
key type I interferon regulated by transcription factors including
IRF-3 and IRF-7 and produced early in infection (Wathelet et
al., 1998). By quantitative RT-PCR, MH-S cells increased
expression of interferon β by 2- to 3-fold in response to vaccinia
infection at MOI 0.1. However, there was no change in the
expression of ISG15, RANTES, or IP10, each of which can be
induced primarily by IRF-3 or induced secondarily by type I
interferon signaling through its cognate receptor (Nakaya et al.,
2001). These data suggest that activation of a type I interferon
response to vaccinia infection is incomplete in MH-S cells,
which is consistent with previous work showing that primary
alveolar macrophages from mice can respond to but not produce
interferon β (Punturieri et al., 2004). Therefore, other anti-viral
signaling molecules and/or mechanisms of host defense, such as
Fig. 4. Alveolar macrophages reduce numbers of leukocytes in the lung during vaccinia infection. (A) Mice were injected intratracheally with clodronate or saline
control liposomes on then infected with 5×105 pfu Vac-FL i.n. 2 days later (day 0). Total numbers of CD45(+) leukocytes in the lungs of mice were quantified on days
3 and 5 post-infection (n=3 mice per group at each time point). Numbers of cells in mice treated with clodronate or saline liposomes and then mock infected were
subtracted from the presented data. *Denotes p<0.05. (B, C) Subpopulations of CD45(+) leukocytes present in the lung minces were analyzed by flow cytometry on
days 3 (B) and 5 (C) post-infection. Percentages of various cell types were multiplied by the total number of CD45(+) leukocytes to determine numbers of cells
expressing each cell surface marker. Flow cytometry data are pooled samples from 4–5 mice per treatment normalized to numbers of cells present in mock-infected
mice injected with clodronate or saline liposomes, respectively. (D, E) Numbers of CD11c(+) cells expressing co-stimulatory molecules CD80 or CD86 on days 3 (D)
and 5 (E) post-infection. *Denotes p<0.05, #Denotes p<0.01.
54 R. Rivera et al. / Virology 363 (2007) 48–58phagocytosis, likely enable MH-S cells to reduce vaccinia
infection in co-culture with respiratory epithelium.
Discussion
We demonstrate that alveolar macrophages confer protection
against vaccinia virus infection, functioning to limit local andsystemic replication of virus as quantified by bioluminescence
imaging and plaque assays on excised tissues. Depletion of
alveolar macrophages increases weight loss and changes in body
temperature, showing that these cells limit the overall severity of
disease produced by vaccinia. In the setting of lethal infection,
alveolar macrophages also had a modest effect to prolong
survival of mice. Although images from selected mice show that
Fig. 5. Co-culture of lung epithelial cells with alveolar macrophages limits
vaccinia infection. LA-4 lung epithelial cells were cultured alone or with 1% or
5% added MH-S alveolar macrophages for 2 days prior to infection with Vac-FL
at MOI of 0.1. Numbers of viral pfu were adjusted to account for differing total
numbers of cells in various wells. (A) Photon flux data are shown for Vac-FL
24 h after infection at MOI of 0.1. Data are expressed as mean values±SEM for
background subtracted photon flux normalized to bioluminescence produced
from infection of LA-4 cells alone. (B) Titers of Vac-FL produced 24 h after
infection of LA-4 cells or LA-4 cells cultured with 1% or 5% MH-S cells. Data
are presented as mean values for viral pfu/ml±SEM (n=4 samples per
condition). The lower limits of detection for the assay are 30 pfu/ml. Results are
representative of two independent experiments.
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from plaque assays for the entire cohort of mice demonstrate that
alveolar macrophages consistently reduce viral replication in the
trachea and not the lungs. Alveolar macrophages limited
systemic dissemination of virus to spleen and lymph nodes in
the abdomen. Viral titers in the brain were not affected by
treatment with clodronate versus saline liposomes, although our
previous work suggests that brain infection with vaccinia is due
to direct spread through the olfactory tract rather than systemic
dissemination (Luker et al., 2005). Collectively, these data
emphasize the critical function of alveolar macrophages to
regulate effective host immunity against vaccinia.
Alveolar macrophages function in part by limiting the total
number of inflammatory cells recruited to the lungs in response
to vaccinia infection. In particular, depletion of alveolar
macrophages increases Gr1(+) granulocytes and ER-MP20(+)
cells, the latter of which are progenitors of granulocytes and
monocytes. Prior studies performed predominantly in vitro show
that monocytes/macrophages and potentially neutrophils have
direct roles in controlling replication of vaccinia virus (Jones,1982; Karupiah and Harris, 1995; West et al., 1987). However,
our data show that the enhanced inflammatory response is
associated with more severe disease, indicating that enhanced
recruitment of these cells is detrimental to the host. Our results
are consistent with previous studies showing that the inflam-
matory response to particulate materials and pathogens in the
lungs disrupts integrity of respiratory epithelium and capillaries,
thereby impairing lung exchange and increasing severity of
disease (Moraes et al., 2006). In addition, depletion of alveolar
macrophages increases numbers of CD11c(+) dendritic cells in
the lungs that express co-stimulatorymolecules CD80 andCD86
as markers of activation. It has been demonstrated previously
that depletion of pulmonary macrophages from rats enhances the
ability of dendritic cells to present a model antigen to T
lymphocytes (Holt et al., 1993). Overall, our results establish
that one key function of alveolar macrophages is to limit the
inflammatory response to vaccinia in the lungs, which reduces
viral dissemination of systemic effects of infection.
In addition to reducing numbers of leukocytes in infected
lungs, alveolar macrophages also interact with lung epithelium to
limit infectionwith vaccinia. Using an in vitro co-culturemodel of
alveolar macrophages and lung epithelium, we demonstrated that
addition of as few as 1% alveolar macrophages to lung epithelium
significantly reduced viral gene expression and replication after
infection at low MOI. Although it is difficult to estimate relative
proportions of alveolar macrophages to respiratory epithelium at
sites of infection, alveolar macrophages are known to be recruited
actively to areas of infection and inflammation in the lungs.
Therefore, the ability of alveolar macrophages to reduce vaccinia
infection of lung epithelium in a cell culture model likely
represents another critical function of alveolar macrophages in
host defense against poxviruses in vivo.
Secretion of cytokines and/or phagocytosis are two possible
mechanisms through which alveolar macrophages limit infec-
tion with vaccinia virus. We analyzed the expression of
interferon β and selected interferon stimulated genes in alveolar
macrophages as candidate molecules to reduce viral replication.
Although MH-S alveolar macrophages infected with vaccinia
virus upregulated expression of interferon β, we did not detect
changes in the expression of other interferon-regulated genes.
These data are consistent with previous research showing that
alveolar macrophages lack autocrine stimulation and feed-
forward amplification of interferon signaling in response to
stimulation with poly I:C, although these cells are able to
respond to exogenous type I interferon (Punturieri et al., 2004).
Because we were unable to reliably separate small numbers of
alveolar macrophages from lung epithelial cells, we could not
analyze the expression of interferon-responsive genes in
alveolar macrophages in co-culture conditions. While lung
epithelial cells may secrete type I interferon to activate
interferon signaling in alveolar macrophages, these data suggest
that protective effects of alveolar macrophages may be mediated
by other cytokines or molecules such as nitric oxide (Karupiah
and Harris, 1995). Protective effects of alveolar macrophages
also may be mediated through phagocytosis of virus particles,
thereby sequestering vaccinia from lung epithelium and limiting
infection. This mechanism of host defense is supported by
56 R. Rivera et al. / Virology 363 (2007) 48–58previous research showing that both immune and non-immune
macrophages ingest vaccinia virus (Greer et al., 1974). Further
studies are needed to establish up to what extent secretion of
cytokines, phagocytosis, and/or other mechanisms such as cell-
to-cell contact promote protective effects of alveolar macro-
phages in vitro and in vivo.
In conclusion, the current study establishes that alveolar
macrophages have an essential protective function against
infection with orthopoxviruses. These cells limit the inflamma-
tory response to vaccinia in the lungs, which reduces viral
replication, dissemination, and overall severity of disease.
Modulating the recruitment of neutrophils and other inflamma-
tory cells into the lungs potentially may be effective in reducing
disease severity produced by a natural or intentional infection
with poxviruses.
Materials and methods
Cells
MH-S cells (ATCC) are an SV40 transformed murine
alveolar macrophage cell line derived from Balb/c mice. These
cells retain many morphologic and functional features of
alveolar macrophages and express surface antigens MHC class
I H2d, class II Ia, and CD11B (Mbawuike and Herscowitz,
1989). LA-4 cells are a murine lung epithelial cell line with
characteristics of type II pneumocytes (Stoner et al., 1975). LA-
4 cells were derived from an A/He mouse and have MHC class
I haplotype H2 k. MH-S and Vero cells were cultured in
DMEM medium (Invitrogen) with 10% heat-inactivated fetal
bovine serum, 1% L-glutamine, and 0.1% penicillin–strepto-
mycin in a 5% CO2 incubator at 37 °C. LA-4 cells were
cultured in DMEM medium containing 15% heat-inactivated
fetal bovine serum.
Vaccinia virus
Stocks of Vac-FL, a recombinant Western Reserve vaccinia
virus that expresses firefly luciferase, were prepared and titered
as described previously (Earl et al., 1998; Luker et al., 2005).
Monoclonal antibodies
The following mAbs were used for flow cytometry (BD
Pharmingen): RM4-4 (anti-murine CD4, rat IgG2b), 53-6.72
(anti-murine CD8, rat IgG2b), M1/70 (anti-murine CD11b, rat
IgG2b), HL3 (anti-murine CD11c, hamster IgG1), 2.4G2 (anti-
murine CD16/CD32 Fc block, rat IgG2b), 3/23 (anti-murine
CD40, rat IgG2a), RA-36B2 (anti-murine CD45R/B220, rat
IgG2a), 30-F11 (anti-murine CD45, rat IgG2b), 16-10A1 (anti-
murine CD80, hamster IgG2), GL1 (anti-murine CD86, rat
IgG2a), AF6-120.1 (anti-murine I-Ab MHC class II, mouse
IgG2a), and RB6-8C5 (anti-murine Ly6G Gr-1, rat IgG2b).
mAbs were primarily conjugated with FITC, biotin, or PE;
biotinylated Abs were visualized using streptavidin-PerCP (BD
Pharmingen). Isotype-matched irrelevant control mAbs (BD
Pharmingen) were tested simultaneously in all experiments.In vitro co-culture experiments
1×104 LA-4 cells were plated in 96-well plates, allowed to
adhere for ≈4 h, and then 0–5×102 MH-S cells were added to
wells for 48 h prior to infection. Cells were infected with Vac-
FL at MOI 0.1, adjusting the inoculum for the total number of
cells in wells. Bioluminescence from Vac-FL was quantified
using the IVIS (Xenogen) 24 h after infection (Luker et al.,
2005). Viral titers were determined by plaque assay at these
same time points.
Mouse procedures
All animal procedures were approved by the University
Committee on Use and Care of Animals (UCUCA) at the
University of Michigan. Seven- to ten-week-old male 129 Ev/
Sv mice (Taconic) were used for all experiments. To deplete
alveolar macrophages, mice were injected intratracheally with
100 μl of liposomes containing clodronate (clodronate lipo-
somes). Control mice received liposomes containing saline.
Mice were infected intranasally with various amounts of Vac-
FL in 20 μl sterile DMEM as described in the figure legends.
Anesthetized mice were shaved with clippers to decrease
absorption and scattering of light for bioluminescence imaging.
Animal weights were recorded daily following infection, and
rectal temperatures were measured every 24 h in selected
experiments. Bronchoalveolar lavage and removal of the lungs
for analysis of cells in the pulmonary interstitium were
performed as described previously (Curtis and Kaltreider,
1989) (Osterholzer et al., 2005).
Analysis of BAL samples
Total cells recovered from BAL were counted manually with
a hemocytometer and then stained with Wright–Giemsa for
differential cell counts. The first 1 ml of BAL fluid recovered
from the lungs was used for ELISA studies of cytokines.
Antibody staining and flow-cytometric analysis
Staining of cells in the pulmonary interstitium, including
blockade of FcRs, and analysis by flow cytometry were
performed as described previously (Osterholzer et al., 2005).
Data were collected on a FACScan flow cytometer using
CellQuest software (both from BD Immunocytometry Systems)
and analyzed using FlowJo software (Tree Star). A minimum of
10,000 cells were analyzed per sample. For all analyses,
percentages for matched isotype control antibodies were
subtracted from values obtained for staining with specific
antibodies for individual markers.
Quantitative RT-PCR
RNA was isolated from cultured cells using Trizol (Invitro-
gen) and RNeasy columns (Qiagen) according to the manu-
facturers' protocols. Quantitative RT-PCR using Syber green
detection was performed with the iScript One-Step Kit (Bio-
57R. Rivera et al. / Virology 363 (2007) 48–58Rad) on a MX3000P instrument (Stratagene). Primer sequences
for amplified mouse genes are listed below:Interferon β Forward 5′ AGCTCCAAGAAAGGACGAACAT 3′
Reverse 5′ GCCCTGTAGGTGAGGTTGATCT 3′ISG15 Forward 5′ CAGGACGGTCTTACCCTTTCC 3′
Reverse 5′ AGGCTCGCTGCAGTTCTGTAC 3′IP10 Forward 5′ CCTGCCCACGTGTTGAGAT 3′
Reverse 5′ TGATGGTCTTAGATTCCGGATTC 3′RANTES Forward 5′ GCCCACGTCAAGGAGTATTTCTA 3′
Reverse 5′ ACACACTTGGCGGTTCCTTC 3′GAPDH Forward 5′ TATGTCGTGGAGTCTACTGGT 3′
Reverse 5′ GAGTTGTCATATTTCTCGTGG 3′Data for target gene expression were normalized to GAPDH
as a control.
Virus titration
Viral titers in cells and organs were analyzed by serial
dilution on Vero cells as described previously (Luker et al.,
2005).
Bioluminescence imaging
Bioluminescence imaging was performed with a cryogeni-
cally cooled CCD camera (IVIS) (Xenogen) as described
previously (Luker et al., 2002). ROIs corresponding to the head,
chest, and abdomen of infected mice were used to quantify
bioluminescence as photon flux using software provided with
the IVIS.
Statistics
Pairs of data points were analyzed by t test for statistically
significant differences (p<0.05). Statistics for correlation
coefficients and area-under-the-curve analyses were performed
with commercially available software (Graphpad, Prism).
Acknowledgments
Research was supported by R21AI066192 and RO1
HL082480 from the UHPHS, and Merit Review funds from
the Department of Veterans Affairs. Support for imaging
experiments was provided by NIH R24CA083099 for the
University of Michigan Small Animal Imaging Resource.
References
Broug-Holub, E., Toews, G., van Iwaarden, J., Strieter, R., Kunkel, S., Paine, R.
R., Standiford, T., 1997. Alveolar macrophages are required for protective
pulmonary defenses in murine Klebsiella pneumoniae: elimination of
alveolar macrophages increases neutrophil recruitment but decreases
bacterial clearance and survival. Infect. Immun. 65 (4), 1139–1146.
Curtis, J., Kaltreider, H., 1989. Characterization of bronchoalveolar lympho-
cytes during a specific antibody-forming cell response in the lungs of mice.
Am. Rev. Respir. Dis. 139 (2), 393–400.
Earl, P., Cooper, N., Wyatt, L., Moss, B., 1998. Preparation of cell cultures and
vaccinia virus stocks. In: Ausubel, F.M., Brent, R., Kingston, R.E., Moore,
D.D., Seidman, J.G., Smith, J.A., Struhl, K. (Eds.), Current Protocols in
Molecular Biology. John Wiley and Sons, Inc, pp. 16.16.1–16.16.11.Farbermann, M., Hoffmann, J., Ryerse, J., Demello, D., 2004. fusible signal to
murine alveolar macrophages from lipopolysaccharide- and Escherichia
coli-stimulated lung Type II epithelial cells. Inflammation Res. 53 (9),
475–483.
Fenner, F., Henderson, D., Arita, I., Jezek, Z., Ladnyi, I., 1988. Smallpox and its
eradication. World Health Organization, Geneva.
Greer, B., Delfs, D., McElree, H., 1974. Electron microscope study of the
interaction of vaccinia virus with macrophages from immunized and
nonimmunized rabbits. Infect. Immun. 9 (2), 452–459.
Hjort, M., Brenyo, A., Finkelstein, J., Frampton, M., LoMonaco, M., Stewart, J.,
Johnston, C., D'Angio, C., 2003. Alveolar epithelial cell–macrophage
interactions affect oxygen-stimulated interleukin-8 release. Inflammation 27
(3), 137–145.
Holt, P., Oliver, J., Bilyk, N., McMenamin, C., McMenamin, P., Kraal, G.,
Thepen, T., 1993. Downregulation of the antigen presenting cell function(s)
of pulmonary dendritic cells in vivo by resident alveolar macrophages. J.
Exp. Med. 177 (2), 397–407.
Ishii, H., Hayashi, S., Hogg, J., Fujii, T., Goto, Y., Sakamoto, N., Mukae, H.,
Vincent, R., van Eeden, S., 2005. Alveolar macrophage–epithelial cell
interaction following exposure to atmospheric particles induces the release
of mediators involved in monocyte mobilization and recruitment. Respir.
Res. 6, 87.
Jones, J., 1982. Interactions between human neutrophils and vaccinia virus:
induction of oxidative metabolism and virus inactivation. Pediatr. Res. 16
(7), 525–529.
Karupiah, G., Harris, N., 1995. Inhibition of viral replication by nitric oxide and
its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J.
Exp. Med. 181 (6), 2171–2179.
Knapp, S., Leemans, J., Florquin, S., Branger, J., Maris, N., Pater, J., van
Rooijen, N., van der Poll, T., 2003. Alveolar macrophages have a protective
antiinflammatory role during murine pneumococcal pneumonia. Am. J.
Respir. Crit. Care Med. 167, 171–179.
Leenen, P., Radosevic, K., Voerman, J., Salomon, B., van Rooijen, N.,
Klatzmann, D., van Ewijk, W., 1998. Heterogeneity of mouse spleen
dendritic cells: in vivo phagocytic activity, expression of macrophage
markers, and subpopulation turnover. J. Immunol. 160 (5), 2166–2173.
Luker, G., Bardill, J., Prior, J., Pica, C., Piwnica-Worms, D., Leib, D., 2002.
Noninvasive bioluminescence imaging of herpes simplex virus type 1
infection and therapy in living mice. J. Virol. 76 (23), 12149–12161.
Luker, K., Hutchens, M., Schultz, T., Pekosz, A., Luker, G., 2005.
Bioluminescence imaging of vaccinia virus: effects of interferon on viral
replication and spread. Virology 341 (2), 284–300.
MacLean, J., Zia, W., Pinto, C., Zhao, L., Liu, H., Kradin, R., 1996.
Sequestration of inhaled particulate antigens by lung phagocytes. A
mechanism for the effective inhibition of pulmonary cell-mediated
immunity. Am. J. Pathol. 148, 657–666.
Mbawuike, I., Herscowitz, H., 1989. MH-S, a murine alveolar macrophage cell
line: morphological, cytochemical, and functional characteristics. J. Leukoc.
Biol. 46 (2), 119–127.
Moraes, T., Zurawska, J., Downey, G., 2006. Neutrophil granule contents in the
pathogenesis of lung injury. Curr. Opin. Hematol. 13 (1), 21–27.
Nakaya, T., Sato, M., Hata, N., Asagiri, M., Suemori, H., Noguchi, S., Tanaka,
N., Taniguchi, T., 2001. Gene induction pathways mediated by distinct IRFs
during viral infection. Biochem. Biophys. Res. Commun. 283 (5),
1150–1156.
Osterholzer, J., Ames, T., Polak, T., Sonstein, J., Moore, B., Chensue, S.,
Toews, G., Curtis, J., 2005. CCR2 and CCR6, but not endothelial
selectins, mediate the accumulation of immature dendritic cells within the
lungs of mice in response to particulate antigen. J. Immunol. 175 (2),
874–883.
Punturieri, A., Alviani, R., Polak, T., Copper, P., Sonstein, J., Curtis, J., 2004.
Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated
innate signal amplification and STAT1 phosphorylation in resident murine
alveolar macrophages. J. Immunol. 173 (2), 1033–1042.
Qian, Q., Jutila, M., van Rooijen, N., Cutler, J., 1994. Elimination of mouse
splenic macrophages correlates with increased susceptibility to experimental
disseminated candidiasis. J. Immunol. 152 (10), 5000–5008.
Stoner, G., Kikkawa, Y., Kniazeff, A., Miyai, K., Wagner, R., 1975. Clonal
58 R. Rivera et al. / Virology 363 (2007) 48–58isolation of epithelial cells from mouse lung adenoma. Cancer Res. 35 (8),
2177–2185.
Thepen, T., Kraal, G., Holt, P., 1994. The role of alveolar macrophages in
regulation of lung inflammation. Ann. N. Y. Acad. Sci. 725, 200–206.
Tuthill, T., Papadopoulos, N., Jourdan, P., Challinor, L., Sharp, N., Plumpton,
C., Shah, K., Barnard, S., Dash, L., Burnet, J., Killington, R., Rowlands, D.,
Clarke, N., Blair, E., Johnston, S., 2003. Mouse respiratory epithelial cells
support efficient replication of human rhinovirus. J. Gen. Virol. 84,
2829–2836.
van den Broek, M., Muller, U., Huang, S., Aguet, M., Zinkernagel, R., 1995.Antiviral defense in mice lacking both alpha/beta and gamma interferon
receptors. J. Virol. 69 (8), 4792–4796.
vanRooijen, N., 1989. The liposome-mediated macrophage ‘suicide’ technique.
J. Immunol. Methods 124 (1), 1–6.
Wathelet, M., Lin, C., Parekh, B., Ronco, L., Howley, P., Maniatis, T.,
1998. Virus infection induces the assembly of coordinately activated
transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1 (4),
507–518.
West, B., Eschete, M., Cox, M., King, J., 1987. Neutrophil uptake of vaccinia
virus in vitro. J. Infect. Dis. 156 (4), 597–606.
